Tr1 lymphocytes have been detected in both tumor tissue and peripheral blood of EBV+ cHL patients, and configure a regulatory subset lacking Foxp3, but usually expressing integrin subunit alpha 2 (ITGA2) and lymphocyte-activation gene 3 (LAG3) [51,52]. The gene discussed is ITGA2; the disease is neoplasm.